The diagnosis and treatment of tardive disorders

William T. Dauer Md, Stanley Fahn Md, Robert E. Burke Md

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Drugs that block dopamine receptors (dopamine receptor blocking agents; DRBA) may cause a variety of movement disorder syndromes. Among these syndromes are the tardive disorders, which are characterized by an onset weeks to years after the start of DRBA therapy and persist or even worsen after DRBA discontinuation. The tardive disorders may sometimes be permanent. The most common tardive disorders are oral-buccal-lingual dyskinesia, tardive dystonia, and tardive akathisia. The clinical characteristics and treatment of these syndromes are reviewed. Initial evaluation of a patient with a tardive disorder should focus on whether the offending DRBA may be discontinued, and whether the symptoms are severe enough to warrant symptomatic therapy. If it is necessary to continue antipsychotic therapy, consideration should be given to the novel antipsychotic clozapine, which does not cause tardive syndromes and may even ameliorate them. In general, the dopamine depletors reserpine and tetrabenazine are the most effective agents in the symptomatic treatment of the tardive syndromes. Other medications used in the treatment of the tardive syndromes are also reviewed.

Original languageEnglish (US)
Pages (from-to)119-125
Number of pages7
JournalMedical Update for Psychiatrists
Volume3
Issue number4
DOIs
StatePublished - Jul 1998

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The diagnosis and treatment of tardive disorders'. Together they form a unique fingerprint.

Cite this